OrbiMed’s Raptor Pharmaceutical RPTP Stock Holding History
Bought
Maintained
Sold
Other funds holding RPTP
OrbiMed's RPTP Position: Q2 2014 in Review
OrbiMed sold out of Raptor Pharmaceutical (RPTP) in Q2 2014, closing a stake of 600,000 shares — an estimated $6M sold.
OrbiMed first reported a position in RPTP in Q1 2014 and held it in 1 quarter. The position peaked at $6M in Q1 2014. 74 funds tracked by Wall St. Rank hold RPTP as of Q2 2014.
- OrbiMed reported no remaining Raptor Pharmaceutical position as of Q2 2014 after selling out during the quarter.
- OrbiMed sold 600,000 Raptor Pharmaceutical shares in Q2 2014, an estimated $6M.
- OrbiMed first reported a position in Raptor Pharmaceutical in Q1 2014 and held it in 1 quarter.
- OrbiMed's Raptor Pharmaceutical position peaked at $6M in Q1 2014.
- 74 funds tracked by Wall St. Rank held Raptor Pharmaceutical as of Q2 2014.
Based on OrbiMed's 13F filing for Q2 2014, filed 14 Aug 2014.